Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Empresa británica busca un desarrollador de una plataforma de fácil manejo para su modelo predictivo de enfermedades crónicas

Resumen

Tipo:
Demanda Tecnológica
Referencia:
TRUK20190823001
Publicado:
23/09/2019
Caducidad:
23/09/2020
Resumen:
Una empresa británica, que ha desarrollado un modelo para predecir las demandas de salud del futuro, busca un socio con el fin de establecer un acuerdo de cooperación técnica y desarrollar una plataforma de fácil manejo para su modelo predictivo de enfermedades crónicas. El objetivo de esta cooperación es aumentar la velocidad del programa y ofrecer soporte en el desarrollo de modelos para modelar el desarrollo de la interfaz de usuario escrita en C++. La experiencia del socio en IA en salud también será beneficiosa porque proporcionaría asistencia a largo plazo en el desarrollo de la estrategia de IA además de la integración de la plataforma actual. Las mejoras del modelo permitirán aumentar la velocidad. El modelo puede utilizarse por compañías farmacéuticas para tomar decisiones de inversión sobre medicamentos para enfermedades crónicas y comprender el impacto a nivel de población en el futuro. La empresa busca compañías del sector farmacéutico/sanitario para establecer acuerdos de licencia.

Details

Tittle:
UK company are seeking a partner to develop a user-friendly platform for their existing chronic disease predictive model
Summary:
UK company that has developed a model that predicts future healthcare demands are seeking a partner under a technology cooperation agreement, to develop its model speed and enable it to be licensed out.
Currently, the UK company has to acquire the data from the pharma/healthcare companies, analyse it and then submit the results back to them which delays the process. The technical enhancements will enable the pharma/healthcare companies to complete the input and analysis themselves.
Description:
The UK company has developed a health predictive model which has been operating in the charity sector for the past 10 years is seeking a technology cooperation agreement with a partner to develop a user-friendly platform for their existing chronic disease model.
The aim of seeking a technology partnership is to improve the speed of the program and to provide support in the models development for the health tech modeling the development of the user interface written in C++, also expertise in AI health would also be beneficial as this could provide long term support in the development of the AI strategy alongside the integration of the existing platform. The improvements to the model will improve its speed enabling it to be licensed to other users.

Currently, each project is bespoke with the UK company having to collate the data which is obtained by the pharma/healthcare company and then the UK company has to input the information into the predictive model, which generates the data and the results are then relayed back to the pharma/healthcare company. The technology partnership´s aim is to develop the model so that it can be licensed to the end-user, with little input from the UK company apart from training on how to use the model, and how to analyse the data produced.

The pharma/healthcare companies under their licensing agreement would have greater control over how they use the model, they could also use the model for numerous analysis projects.

The model could be used by pharma to make investment decisions around chronic disease drugs by understanding their population-level impact into the future.

The model can create an entire virtual population (20million individuals), where individuals can be followed through their life, with interventions at different points.

The model can quantify impacts of a range of interventions from policy/prevention, screening, and treatment over the long-term, and quantify the impact of these interventions if they were to be scaled up in the real world.
The data produced would allow the pharma/healthcare sector to be able to predict where the demand will be in chronic disease in relation to treatments and pharmaceuticals, this will provide them with guidance for future planning also being able to assess the financial implications.
The following outlines the benefits that the model offers.
- Being able to look 10 to 20 years ahead to understand a new drug´s impact on its users and your revenue stream? (pharmaceuticals)

- It can boost a nation´s health with targeted help at different life stages (Government/Health Insurance)

- What impact will different levels of air quality have on healthcare costs between now and 2050 (Government/NGO)

- The model can run a virtual clinical trial to help make the real one less expensive and more efficient (Academia/pharmaceutical)

- What impact would a tax on sugary drinks have on reducing obesity over the next 20 years (Government/NGO)

-What impact would your medical device have if everyone in the patient population used it (Pharmaceuticals/biotech companies)

The simulation and analysis expertise generated by the model can turn tomorrow´s population health questions into today´s focussed, specific, actionable decisions. It can help clients to understand and explore population health questions and challenges over the decades to come.
The model can analyse on how different kinds of health interventions, innovations, and policy changes can impact clients helping them to decide on the most effective, transformative ways of responding to them.
Technical Specification or Expertise Sought:
- Specific expertise would be around health tech with a user interface (written in C++)

- Expertise in AI for health platforms with knowledge on how to integrate within existing platforms
- The partner could be an enterprise, enterprise manufacturer, research centre or university.

Partner sought

Type and Role of Partner Sought:
A partner is needed under a technical cooperation agreement to develop the medical predictive model so that it can be licensed to companies in the pharma and healthcare sector.
The partner could be an enterprise, enterprise manufacturer, research center or a university

Client

Type and Size of Client:
Industry SME <= 10
Already Engaged in Trans-National Cooperation:
No
Languages Spoken:
English